Lithium toxicity after switch from fosinopril to lisinopril

International Clinical Psychopharmacology

Volumn 20, Issue 2, 2005, Pages 115-118

  Meyer, Jonathan M ^a,c   Dollarhide, Adrian ^a,b   Tuan, In Lin ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Angiotensin converting enzyme inhibitor; Fisinopril; Fosinopril; Lithium; Toxicity

Indexed keywords

ATENOLOL; BENZATROPINE; CLONAZEPAM; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FOSINOPRIL; HALOPERIDOL; LISINOPRIL; LITHIUM; NEUROLEPTIC AGENT; OLANZAPINE; SIMVASTATIN; VALPROATE SEMISODIUM; VALPROIC ACID;

ADULT; ARTICLE; BRADYCARDIA; CASE REPORT; CLINICAL FEATURE; CREATININE BLOOD LEVEL; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG EFFECT; DRUG TOXICITY; FOLLOW UP; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; HYPERLIPIDEMIA; HYPERSALIVATION; HYPERTENSION; KIDNEY FUNCTION; MALE; PATIENT MONITORING; POSTURAL TREMOR; PRIORITY JOURNAL; REHYDRATION; SCHIZOAFFECTIVE PSYCHOSIS; SYMPTOM; TREMOR;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRADYCARDIA; FOSINOPRIL; HEART RATE; HUMANS; LISINOPRIL; LITHIUM; MALE; MIDDLE AGED; PSYCHOTIC DISORDERS;

EID: 14844356471     PISSN: 02681315     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004850-200503000-00010     Document Type: Article

References (34)

1. Ahmad S (1990). ACE inhibitors and lithium. Postgrad Med 87:31.
2. Alderman CP, Lindsay KS (1996). Increased serum lithium concentration secondary to treatment with tiaprofenic acid and fosinopril. Annal Pharmacother 30:1411-1413.
3. Baldwin CM, Safferman AZ (1990). A case of lisinopril-induced lithium toxicity. DICP 24:946-947.
4. Chandragiri SS, Pasol E, Gallagher RM (1998). Lithium ACE inhibitors, NSAIDs, and verapamil. A possible fatal combination. Psychosomatics 39:281-282.
5. Correa FJ, Eiser AR (1992). Angiotensin-converting enzyme inhibitors and lithium toxicity. Am J Med 93:108-109.
6. DasGupta K, Jefferson JW, Kobak KA, Greist JH (1992). The effect of enalapril on serum lithium levels in healthy men. J CHn Psychiatry 53:398-400.
7. Davies NM, Teng XW, Skjodt NM (2003). Pharmacokinetics of rofecoxib: a specific cyclo-oxygenase-2 inhibitor. Clin Pharmacokinet 42:545-556.
8. Delva NJ, Hawken ER (2001). Preventing lithium intoxication. Guide for physicians. Can Fam Physician 47:1595-1600.
9. Douste-Blazy P, Rostin M, Livarek B, Tordjman E, Montastruc JL, Galinier F (1986). Angiotensin converting enzyme inhibitors and lithium treatment. Lancet 1:1448.
10. Drouet A, Bouvet O (1990). Lithium and converting enzyme inhibitors. Encephale 16:51-52.
11. Finley PR, O'Brien JG, Coleman RW (1996). Lithium and angiotensin-converting enzyme inhibitors: evaluation of a potential interaction. J Clin Psychopharmacol 16:68-71.
12. Gitlin M (1999). Lithium and the kidney: an updated review. Drug Safety 20: 231-243.
13. Greenbaum R, Zucchelli P, Caspi A, Nouriel H, Paz R, Sclarovsky S, et al. (2000). Comparison of the pharmacokinetics of fosinoprilat with enalaprilat and lisinopril in patients with congestive heart failure and chronic renal insufficiency. Br J Clin Pharmacol 49:23-31.
14. Griffin JH, Hahn SM (1991). Lisinopril-induced lithium toxicity. DICP 25:101.
15. Hardman TC, Wierzbicki AS, Croft P, Feher M, Cox A, Lant AF (1996). Angiotensin-converting enzyme (ACE) gene polymorphism and the erythrocyte sodium-lithium countertransporter (SLC) phenotype in hypertension. J Hum Hypertens 10:429-430.
16. Imbs JL, Barthelmebs M, Danion JM, Singer L (1997). Mechanisms of drug interactions with renal elimination of lithium. Bull Acad Nat Med 181: 685-697.
17. Johnson G (1998). Lithium - early development, toxicity, and renal function. Neuropsychopharmacology 19:200-205.
18. Juurlink DN, Mamdani MM, Kopp A, Rochon PA, Shulman KI, Redelmeier DA (2004). Drug-induced lithium toxicity in the elderly: a population-based study. J Am Geriatr Soc 52:794-798.
19. Kelly JG, O'Malley K (1990). Clinical pharmacokinetics of the newer ACE inhibitors: a review. Clin Pharmacokinet 19:177-196.
20. Lehmann K, Ritz E (1995). Angiotensin-converting enzyme inhibitors may cause renal dysfunction in patients on long-term lithium treatment. Am J Kid Dis 25:82-87.
21. Mahieu M, Houvenagel E, Leduc JJ, Choteau P (1988). Lithium-converting enzyme inhibitors: a combination to avoid? Presse Med 17:281.
22. Markowitz GS, Radhakrishnan J, Kambham N, Valeri AM, Hines WH, D'Agati VD (2000). Lithium nephrotoxicity: a progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 11:1439-1448.
23. Meltzer E, Steinlauf S (2002). The clinical manifestations of lithium intoxication. Israel Med Assoc J 4:265-267.
24. Moltedo JM, Porter GA, State MW, Snyder CS (2002). Sinus node dysfunction associated with lithium therapy in a child. Texas Heart Inst J 29:200-202.
25. Navis GJ, de Jong PE, de Zeeuw D (1989). Volume homeostasis, angiotensin converting enzyme inhibition, and lithium therapy. Am J Med 86:621.
26. Oakley PW, Whyte IM, Carter GL (2001). Lithium toxicity: an iatrogenic problem in susceptible individuals. Austral NZ J Psychiatry 35:833-840.
27. Phelan KM, Mosholder AD, Lu S (2003). Lithium interaction with the cyclooxygenase 2 inhibitors rofecoxib and celecoxib and other nonsteroidal anti-inflammatory drugs. J Clin Psychiatry 64:1328-1334.
28. Pulik M, Lida H (1988). Interaction of lithium and angiotensin-converting enzyme inhibitors. Presse Med 17:755.
29. Song JC, White CM (2002). Clinical pharmacokinetics and selective pharmacology of new angiotensin converting enzyme inhibitors: an update. Clin Pharmacokinet 41:207-224.
30. Timmer RT, Sands JM (1999). Lithium intoxication. J Am Soc Nephrol 10: 666-674.
31. Verme-Gibboney C (1997). Oral angiotensin-converting-enzyme inhibitors. Am J Health Syst Pharm 54:2689-2703.
32. Vipond AJ, Bakewell S, Telford R, Nicholls AJ (1996). Lithium toxicity. Anaesthesia 51:1156-1158.
33. Webb AL, Solomon DA, Ryan CE (2001). Lithium levels and toxicity among hospitalized patients. Psychiatr Serv 52:229-231.
34. Zwanzger P, Marcuse A, Boerner RJ, Walther A, Rupprecht R (2001). Lithium intoxication after administration of AT1 blockers. J Clin Psychiatry 62: 208-209.